UNSPSC 51282529: Cefazaflur sodium

This classification denotes the sodium form of a cephalosporin antibiotic with the molecular structure C13H13F3N6O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 97I0692RNT chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-7-((((trifluoromethyl)thio)acetyl)amino)-, (6r-trans)-, but more commonly known as cefazaflur, which bears US NIH Compound Identifier 40239.

UNSPSC 51282529 Cefazaflur sodium is a Commodity code that nominally describes a specific pharmaceutical ingredient, but recent state and local opportunities tagged under this code show little activity directly aligned with that product line. The most recent solicitations under this code actually procure naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and market research on direct-to-manufacturer prescription programs. The issuing bodies span county health departments, municipal fire departments, state pharmacy benefit programs, and multi-state cooperative purchasing alliances. The mismatch between the code's nominal scope and the actual work being solicited suggests either tagging inconsistency in the source data or that this code is being applied broadly to pharmaceutical procurement activity beyond its specific ingredient designation.

Recent opportunities show geographic activity across Florida, Texas, Minnesota, and Oregon. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note the date inconsistency in source records). The City of Tampa's Purchasing Department solicited medical and first aid supplies (IFB 26P00145) estimated at $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, administered through three authorized wholesalers. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, as a preliminary market-intelligence exercise on direct-to-manufacturer prescription programs. The code shows sparse, scattered activity with no clear concentration in a single jurisdiction or procurement strategy.